Evidence map›Paper›PMID 23601806›Full record

ArticleOphthalmology2013

Ocular manifestations of xeroderma pigmentosum: long-term follow-up highlights the role of DNA repair in protection from sun damage.

Brian P Brooks, Amy H Thompson, Rachel J Bishop, Janine A Clayton, Chi-Chao Chan, Ekaterini T Tsilou, Wadih M Zein, Deborah Tamura, Sikandar G Khan, Takahiro Ueda and 10 more

Open access · greenAbstract readCase Reports
In one paragraph

Article in Ophthalmology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 88 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Xeroderma Pigmentosum: A Model for Human Premature Aging.The Journal of investigative dermatology · 2021
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 6 institutions in 1 country.

Brian P BrooksNational Eye Institute, National Institutes of Health, Bethesda, Maryland 20892, USA. brooksb@mail.nih.gov
Amy H Thompson
Rachel J Bishop
Janine A Clayton
Chi-Chao Chan
Ekaterini T Tsilou
Wadih M Zein
Deborah Tamura
Sikandar G Khan
Takahiro Ueda
Jennifer Boyle
Kyu-Seon Oh
Kyoko Imoto
Hiroki Inui
Shin-Ichi Moriwaki
Steffen Emmert
Nicholas T Iliff
Porcia Bradford
John J Digiovanna
Kenneth H Kraemer
Center for Cancer Research · USNational Cancer Institute · USNational Eye Institute · USNational Institutes of Health · USDivision of Cancer Epidemiology and GeneticsJohns Hopkins University · US

Funding

The Genetics of Uveal ColobomaZIAEY000469 · NEI · NATIONAL EYE INSTITUTE · PI BROOKS, BRIAN · 2009 to 2025
$35.2M
DNA Repair in Human Cancer-Prone Genetic DiseasesZIABC004517 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KRAEMER, KENNETH H · 2009 to 2024
$26.5M
Histopathology CoreZICEY000461 · NEI · NATIONAL EYE INSTITUTE · PI SCHNEEWEIS, DAVID · 2009 to 2022
$7.7M
Ophthalmic Genetics FellowshipZIEEY000477 · NEI · NATIONAL EYE INSTITUTE · PI HURYN, LARYSSA · 2009 to 2025
$7.2M
Molecular And Immunopathology Of Experimental And Clinical Ocular DiseasesZIAEY000222 · NEI · NATIONAL EYE INSTITUTE · PI CHAN, CHI-CHAO · 2009 to 2015
$7.2M
Natural History of Ocular GVHDZIAEY000512 · NEI · NATIONAL EYE INSTITUTE · PI BISHOP, RACHEL · 2012 to 2016
$1.1M
Topical Cysteamine to Tx Corneal Cystine Crystal Accumulation in CystinosisZIAEY000519 · NEI · NATIONAL EYE INSTITUTE · PI BISHOP, RACHEL · 2012 to 2013
$192k
Intramural NIH HHS Z99 EY999999
6 · The paper itself

Abstract

objectiveXeroderma pigmentosum (XP) is a rare autosomal recessive disease caused by mutations in DNA repair genes. Clinical manifestations of XP include mild to extreme sensitivity to ultraviolet radiation resulting in inflammation and neoplasia in sun-exposed areas of the skin, mucous membranes, and ocular surfaces. This report describes the ocular manifestations of XP in patients systematically evaluated in the Clinical Center at the National Institutes of Health.

designRetrospective observational case series.

participantsEighty-seven participants, aged 1.3 to 63.4 years, referred to the National Eye Institute (NEI) for examination from 1964 to 2011. Eighty-three patients had XP, 3 patients had XP/Cockayne syndrome complex, and 1 patient had XP/trichothiodystrophy complex.

methodsComplete age- and developmental stage-appropriate ophthalmic examination.

main outcome measuresVisual acuity; eyelid, ocular surface, and lens pathology; tear film and tear production measures; and cytologic analysis of conjunctival surface swabs.

resultsOf the 87 patients, 91% had at least 1 ocular abnormality. The most common abnormalities were conjunctivitis (51%), corneal neovascularization (44%), dry eye (38%), corneal scarring (26%), ectropion (25%), blepharitis (23%), conjunctival melanosis (20%), and cataracts (14%). Thirteen percent of patients had some degree of visual axis impingement, and 5% of patients had no light perception in 1 or both eyes. Ocular surface cancer or a history of ocular surface cancer was present in 10% of patients. Patients with an acute sunburning skin phenotype were less likely to develop conjunctival melanosis and ectropion but more likely to develop neoplastic ocular surface lesions than nonburning patients. Some patients also showed signs of limbal stem cell deficiency.

conclusionsOur longitudinal study reports the ocular status of the largest group of patients with XP systematically examined at 1 facility over an extended period of time. Structural eyelid abnormalities, neoplasms of the ocular surface and eyelids, tear film and tear production abnormalities, ocular surface disease and inflammation, and corneal abnormalities were present in this population. Burning and nonburning patients with XP exhibit different rates of important ophthalmologic findings, including neoplasia. In addition, ophthalmic characteristics can help refine diagnoses in the case of XP complex phenotypes. DNA repair plays a major role in protection of the eye from sunlight-induced damage.

Indexed as

AdolescentAdultChildChild, PreschoolCockayne SyndromeDNADNA RepairEye DiseasesFemaleFollow-Up StudiesHumansInfantMaleMiddle AgedRadiation InjuriesRetrospective StudiesDNA

Identifiers

PMID23601806
PMCPMC3702678
OpenAlexW98249881

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.